Top compounds associated with response to RIMKLB


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC 0.062 0.05
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA AZD6244 UHNBreast pan-cancer AAC 0.54 0.06
mRNA narciclasine CTRPv2 pan-cancer AAC 0.063 0.06
mRNA Doxorubicin gCSI pan-cancer AAC 0.1 0.06
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.066 0.06
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.056 0.06
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.06
mRNA paclitaxel GDSC1000 pan-cancer AAC -0.099 0.06
Download CSV